Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jun 4;30(8):1554–1565. doi: 10.1158/1055-9965.EPI-20-1809

Table 1.

Percentage of adults aged 50-75 up-to-date with CRC screening by test type, sex, and age, National Health Interview Survey, 2018.

Any CRC
screening testa
Colonoscopy
within 10 years
FOBT/FITb
within 1 year
FIT-DNA
within 3 years
Sigmoidoscopy
within 5 years
CT colonography
within 5 years
N %
(95% CI)
P %
(95% CI)
P %
(95% CI)
P %
(95% CI)
P %
(95% CI)
P %
(95% CI)
P
Total 10,595 66.9
(65.8-68.1)
61.1
(59.9-62.3)
8.8
(8.1-9.5)
2.7
(2.4-3.2)
2.4
(2.1-2.8)
1.0
(0.8-1.3)
Sex 0.43 0.61 0.04 0.19 0.09 0.11
Male 4,846 67.4
(65.8-69.0)
61.4
(59.8-63.1)
9.5
(8.5-10.6)
2.5
(2.0-3.1)
2.7
(2.2-3.4)
1.2
(0.9-1.7)
Female 5,749 66.5
(64.9-68.1)
60.8
(59.1-62.5)
8.1
(7.3-9.1)
3.0
(2.5-3.5)
2.1
(1.6-2.6)
0.8
(0.6-1.2)
Age (years) <0.001 <0.001 <0.001 <0.001 0.01 0.17
50-64 6,294 61.8
(60.2-63.3)
55.9
(54.3-57.5)
7.9
(7.0-8.8)
2.2
(1.8-2.8)
2.1
(1.7-2.5)
0.9
(0.7-1.2)
65-75 4,301 76.9
(75.4-78.4)
71.1
(69.5-72.8)
10.5
(9.4-11.7)
3.7
(3.1-4.5)
3.0
(2.4-3.7)
1.2
(0.9-1.7)
a

Any CRC screening test within the recommended time period (up-to-date with CRC screening) defined as either colonoscopy within the past 10 years, CT colonography or sigmoidoscopy within the past 5 years, FOBT or FIT within the past year, or FIT-DNA within the past 3 years.

b

Use of FOBT/FIT does not include a FIT that the respondent reported was conducted as part of a FIT-DNA test.